With billions in potential savings for Medicare at stake, we asked drug experts and practitioners alike why more doctors don’t recommend generics when they can.
The death of American exceptionalism—and of me.
Why isn’t required for every newborn?
An Inspector General’s report faults Medicare for not tracking abuses in prescriptions.
Though agents found blatant fraud in a Houston lab, the FDA refused to question drug safety.
In a second case of flawed drug research, FDA response was slow and secretive.
Did a company try to hide risks of MRI dye Omniscan?
The best remedy is transparency.
A personal encounter with the complexity and errors of the modern healthcare system.
Journalist Mina Kimes discusses illegal drug experiments and medical catastrophe.
“Toxic Beauty,” a retrospective at NYU’s Grey Gallery, brings together the writing and visual work of an extraordinarily socially engaged artist.